S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway.

BACKGROUND:Esophageal squamous cell carcinoma (ESCC) is one of the most common cancers worldwide, which lacks effective biomarkers for prognosis. Therefore, it is urgent to explore new potential molecular markers to discriminate patients with poorer survival in ESCC. METHODS:Bioinformatics analysis, qRT-PCR, and western blot were applied to investigate S1PR1 expression. CCK-8 assay, colony formation assay, flow cytometry dual staining assay, and immunofluorescence were performed to examine cell proliferation ability and apoptosis rate. Mouse xenograft model of TE-13 cells was established to confirm the roles of S1PR1 in vivo. Gene set enrichment analysis (GSEA) was used to investigate the downstream signaling pathways related to S1PR1 functions. Co-IP was performed to verify the direct binding of S1PR1 and Western blot was applied to determine the phosphorylation level of duanyu18133. Immunohistochemistry was conducted to identify protein expression of S1PR1 and p- in tumor tissues. RESULTS:In the present study, we found that S1PR1 expression was higher in ESCC patients and was a potential biomarker for poor prognosis. Silencing S1PR1 expression inhibited proliferation, and increased apoptosis of ESCC cells, while overexpression of S1PR1 had opposite effects. Mechanistically, S1PR1 played the roles of promoting proliferation and attenuating apoptosis through directly activating Furthermore, in vivo experiments verified this mechanism. CONCLUSION:Our findings indicated that S1PR1 enhanced proliferation and inhibited apoptosis of ESCC cells by activating duanyu18133 signaling pathway. S1PR1 may serve as a prognostic biomarker for clinical applications.

KEYWORDS: {{ getKeywords(articleDetailText.words) }}